Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Asset Writedowns and Impairment (2016 - 2026)

Exponent (EXPO) has disclosed Asset Writedowns and Impairment for 17 consecutive years, with $891000.0 as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Asset Writedowns and Impairment fell 31.98% year-over-year to $891000.0, compared with a TTM value of $3.0 million through Jan 2026, down 32.85%, and an annual FY2026 reading of $3.0 million, down 32.85% over the prior year.
  • Asset Writedowns and Impairment was $891000.0 for Q1 2026 at Exponent, down from $1.5 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $1.5 million in Q4 2025 and bottomed at $256000.0 in Q2 2025.
  • Average Asset Writedowns and Impairment over 5 years is $859000.0, with a median of $837500.0 recorded in 2022.
  • The sharpest move saw Asset Writedowns and Impairment surged 174.11% in 2024, then crashed 79.98% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at $969000.0 in 2022, then skyrocketed by 35.6% to $1.3 million in 2023, then tumbled by 40.56% to $781000.0 in 2024, then skyrocketed by 93.47% to $1.5 million in 2025, then plummeted by 41.03% to $891000.0 in 2026.
  • Business Quant data shows Asset Writedowns and Impairment for EXPO at $891000.0 in Q1 2026, $1.5 million in Q4 2025, and $330000.0 in Q3 2025.